Apollo Therapeutics
Portfolio biopharmaceutical company developing new medicines from university biomedical research and in-licensed clinical programs
Highlights
- New on EvolcAdded 2026-11-01
About Apollo Therapeutics
Apollo Therapeutics is a portfolio biopharmaceutical company. It translates breakthroughs in biology and basic medical research into new medicines, and reports over 20 active therapeutic programs, six of which are in development. It also in-licenses or acquires clinical-stage programs to grow its portfolio.
The company works with six universities and research institutes, including the University of Cambridge, UCL, Imperial College London, King's College London and The Institute of Cancer Research. It is backed by specialist investors including Patient Square Capital and Rock Springs Capital. In 2021 it raised a $145m Series B financing to become an independent portfolio biopharma company.
Apollo Therapeutics was formed in 2016 as a joint venture between three universities and three pharmaceutical companies. It is headquartered in Cambridge, UK, and also has offices in Oxford, UK, and in Boston and Chicago, USA. Its team is based in the UK and the USA.
Product: Portfolio of over 20 active therapeutic programs, six in development, built from university breakthroughs and in-licensed clinical-stage assets.
Jobs at Apollo Therapeutics
Leadership
- Sanjay Aggarwal · Chief Medical OfficerSource: company website
- Clare Burles · VP, People and CommunicationsSource: company website
More biotech & pharma companies
Apterna
Preclinical biotech developing liver-directed RNA therapies to restore liver function for patients with liver cancerNew on EvolcArecor
Develops therapeutics for people with diabetes, obesity and other cardiometabolic diseasesNew on EvolcAspire Pharma
Specialty and niche generic medicines for patients, healthcare professionals and health systems in the UK and international marketsNew on EvolcRemote-friendlyAstute Healthcare
Wholesale distributor of medicines and FMCG health and personal care products to pharmacies, retailers and hospitals in the UKNew on EvolcAutolus
Develops engineered T-cell therapies for patients with cancer and autoimmune diseasesNew on EvolcRemote-friendlyAutomata
Lab automation hardware and software for life science labs, including workflow orchestration and configurable lab benchesNew on EvolcRemote-friendly
Website technologies
Tools and platforms detected on this company’s website, grouped by purpose. Dates record when Evolc observed them.
Analytics
- Google Tag ManagerMedium confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Integration code on pageinline script loader
Content management
- WordPressHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
Forms
- Google reCAPTCHAHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
Frontend frameworks
- jQueryHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
Hosting
- ApacheHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Response headerserver
- Response headerserver
- Response headerserver
- AWSHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
Website detection does not establish a paid subscription or company-wide use. Tools loaded after consent or sign-in may be missed. “No longer observed” does not prove the company stopped using a tool.